{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:26:34Z","timestamp":1791523594506,"version":"4.3.4"},"reference-count":288,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajps.2026.101121","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:52:43Z","timestamp":1777621963000},"page":"101121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The evolution of lipid nanoparticles: Paving the way for next-generation nucleic acid medicines"],"prefix":"10.1016","volume":"21","author":[{"given":"Xuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9586-7373","authenticated-orcid":false,"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2026.101121_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113834","article-title":"Nucleic acid delivery for therapeutic applications","volume":"178","author":"Gupta","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0002","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/med.21479","article-title":"Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy","volume":"38","author":"Chen","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0003","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"MRNA vaccines: a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajps.2026.101121_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201901081","article-title":"Cancer-targeting nanoparticles for combinatorial nucleic acid delivery","volume":"32","author":"Vaughan","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0005","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/dmd.121.000417","article-title":"Absorption, distribution, metabolism, and excretion of us food and drug administration-approved antisense oligonucleotide drugs","volume":"50","author":"Migliorati","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajps.2026.101121_bib0006","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"Covid-19 mRNA vaccines: platforms and current developments","volume":"30","author":"Szab\u00f3","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0007","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in covid-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0008","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"MRNA-based therapeutics \u2014 Developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajps.2026.101121_bib0009","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.3390\/cancers13195002","article-title":"Nucleic acid drugs-current status, issues, and expectations for exosomes","volume":"13","author":"Yamada","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajps.2026.101121_bib0010","doi-asserted-by":"crossref","first-page":"8888","DOI":"10.3390\/ijms25168888","article-title":"Nucleic acid armor: fortifying RNA therapeutics through delivery and targeting innovations for immunotherapy","volume":"25","author":"Jiang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0011","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/pharmaceutics15051450","article-title":"Advances and challenges of stimuli-responsive nucleic acids delivery system in gene therapy","volume":"15","author":"Lin","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200006","article-title":"Chemical modifications for a next generation of nucleic acid aptamers","volume":"23","author":"Chan","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.ajps.2026.101121_bib0013","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1080\/15476286.2016.1261788","article-title":"Detection of nucleic acid modifications by chemical reagents","volume":"14","author":"Heiss","year":"2017","journal-title":"RNA Biol"},{"key":"10.1016\/j.ajps.2026.101121_bib0014","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0015","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0016","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajps.2026.101121_bib0017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","article-title":"Non-viral vectors for RNA delivery","volume":"342","author":"Yan","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0018","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/ijms24021592","article-title":"Structures and applications of nucleic acid-based micelles for cancer therapy","volume":"24","author":"Kim","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0019","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/cells9092061","article-title":"Nucleic acid-based approaches for tumor therapy","volume":"9","author":"Hager","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ajps.2026.101121_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106441","article-title":"Nucleic acid therapy in pediatric cancer","volume":"184","author":"Li","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ajps.2026.101121_bib0022","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus Sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0023","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013243","article-title":"Delivery of oligonucleotide-based therapeutics: challenges and opportunities","volume":"13","author":"Hammond","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111596","article-title":"ncRNAs in therapeutics: challenges and limitations in nucleic acid-based drug delivery","volume":"22","author":"Hueso","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-022-01298-z","article-title":"Nucleic acid drug vectors for diagnosis and treatment of brain diseases","volume":"8","author":"Lu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114898","article-title":"Addressing the in vivo delivery of nucleic-acid nanostructure therapeutics","volume":"199","author":"Alexander","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0027","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.3390\/ijms22105264","article-title":"Nucleic acid delivery with red-blood-cell-based carriers","volume":"22","author":"Della Pelle","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103507","article-title":"Oral delivery of nucleic acid therapeutics: challenges, strategies, and opportunities","volume":"28","author":"Jiang","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ajps.2026.101121_bib0029","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1039\/D2NR05316K","article-title":"Stimuli-responsive nucleic acid nanostructures for efficient drug delivery","volume":"14","author":"Yang","year":"2022","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.ajps.2026.101121_bib0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/10717544.2021.2023699","article-title":"Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis","volume":"29","author":"Yan","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ajps.2026.101121_bib0031","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1021\/acs.accounts.2c00464","article-title":"Overcoming pharmaceutical bottlenecks for nucleic acid drug development","volume":"56","author":"Lu","year":"2023","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajps.2026.101121_bib0033","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.omtn.2018.06.010","article-title":"Uridine depletion and chemical modification increase Cas9 mRNA activity and reduce immunogenicity without hplc purification","volume":"12","author":"Vaidyanathan","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ajps.2026.101121_bib0034","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.biotechadv.2013.11.004","article-title":"Design, preparation and application of nucleic acid delivery carriers","volume":"32","author":"Yang","year":"2014","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.ajps.2026.101121_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.12.005","article-title":"Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis","volume":"318","author":"Zhao","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120546","article-title":"Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment","volume":"268","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2026.101121_bib0037","doi-asserted-by":"crossref","first-page":"eabp9435","DOI":"10.1126\/sciadv.abp9435","article-title":"Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases","volume":"8","author":"Wan","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2026.101121_bib0038","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cac2.12275","article-title":"Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma","volume":"42","author":"Zhang","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.ajps.2026.101121_bib0039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/pharmaceutics14010038","article-title":"Optimised electroporation for loading of extracellular vesicles with doxorubicin","volume":"14","author":"Lenna\u00e1rd","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0040","first-page":"207","article-title":"A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis","volume":"10","author":"Cui","year":"2022","journal-title":"Bioact Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0041","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13045-020-00987-y","article-title":"Isolation and characterization of exosomes for cancer research","volume":"13","author":"Zhu","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ajps.2026.101121_bib0042","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41551-017-0119-4","article-title":"Tumour-bound RNA-laden exosomes","volume":"1","author":"Kooijmans","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ajps.2026.101121_bib0043","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.7150\/thno.62330","article-title":"Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies","volume":"11","author":"Xu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2026.101121_bib0044","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","article-title":"Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation","volume":"4","author":"Yang","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ajps.2026.101121_bib0045","article-title":"Functionalized macrophage exosomes with panobinostat and ppm1d-siRNA for diffuse intrinsic pontine gliomas therapy","volume":"9","author":"Shan","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ajps.2026.101121_bib0046","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12974-020-01787-4","article-title":"Nk cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice","volume":"17","author":"Li","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.ajps.2026.101121_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114487","article-title":"Microfluidic-based exosome isolation and highly sensitive aptamer exosome membrane protein detection for lung cancer diagnosis","volume":"214","author":"Zhao","year":"2022","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.ajps.2026.101121_bib0048","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7150\/thno.21945","article-title":"Exosome theranostics: biology and translational medicine","volume":"8","author":"He","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2026.101121_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122544","article-title":"Exosomes based strategies for cardiovascular diseases: opportunities and challenges","volume":"308","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2026.101121_bib0050","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1113\/JP282053","article-title":"Challenges and future scope of exosomes in the treatment of cardiovascular diseases","volume":"601","author":"Ranjan","year":"2023","journal-title":"J Physiol"},{"key":"10.1016\/j.ajps.2026.101121_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116543","article-title":"Research status and challenges of plant-derived exosome-like nanoparticles","volume":"174","author":"Bai","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ajps.2026.101121_bib0052","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","article-title":"Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles","volume":"172","author":"Kooijmans","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0053","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2022.06.049","article-title":"Extracellular vesicles for renal therapeutics: state of the art and future perspective","volume":"349","author":"Tang","year":"2022","journal-title":"J Control Rel"},{"key":"10.1016\/j.ajps.2026.101121_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112163","article-title":"Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy","volume":"209","author":"Liu","year":"2022","journal-title":"Coll Surf B: Biointerf"},{"issue":"1","key":"10.1016\/j.ajps.2026.101121_bib0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for parkinson's disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0056","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biotechadv.2012.10.001","article-title":"Development of hybrid viral vectors for gene therapy","volume":"31","author":"Huang","year":"2013","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.ajps.2026.101121_bib0057","doi-asserted-by":"crossref","first-page":"E731","DOI":"10.1208\/aapsj080483","article-title":"Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems","volume":"8","author":"Boeckle","year":"2006","journal-title":"AAPS J"},{"key":"10.1016\/j.ajps.2026.101121_bib0058","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1586\/14760584.2015.979798","article-title":"RNA-based viral vectors","volume":"14","author":"Mogler","year":"2015","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.ajps.2026.101121_bib0059","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/hep.30160","article-title":"Successful treatment with ledipasvir\/sofosbuvir in an infant with severe combined immunodeficiency caused by adenosine deaminase deficiency with HCV allowed gene therapy with strimvelis","volume":"68","author":"Tucci","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ajps.2026.101121_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.15252\/emmm.201607293","article-title":"Patient-driven search for rare disease therapies: the fondazione telethon success story and the strategy leading to strimvelis","volume":"9","author":"Monaco","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0061","doi-asserted-by":"crossref","first-page":"e3011","DOI":"10.1002\/jgm.3011","article-title":"Polymer-coated viral vectors: hybrid nanosystems for gene therapy","volume":"20","author":"Rajagopal","year":"2018","journal-title":"J Gene Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0062","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.vaccine.2006.07.035","article-title":"Viral vectors for malaria vaccine development","volume":"25","author":"Li","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ajps.2026.101121_bib0063","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2016.02.013","article-title":"Viral vectors for therapy of neurologic diseases","volume":"120","author":"Choudhury","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajps.2026.101121_bib0064","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00109-022-02208-0","article-title":"Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective","volume":"100","author":"Schwartze","year":"2022","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.ajps.2026.101121_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/v9010013","article-title":"Adenoviral vectors armed with cell fusion-inducing proteins as anti-cancer agents","volume":"9","author":"Del Papa","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.ajps.2026.101121_bib0066","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.3390\/ijms21103643","article-title":"High-capacity adenoviral vectors: expanding the scope of gene therapy","volume":"21","author":"Ricobaraza","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0067","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216519","article-title":"Adenoviral gene therapy vectors in clinical use-basic aspects with a special reference to replication-competent adenovirus formation and its impact on clinical safety","volume":"24","author":"Leikas","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0068","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0069","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/v6020832","article-title":"The evolution of adenoviral vectors through genetic and chemical surface modifications","volume":"6","author":"Capasso","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.ajps.2026.101121_bib0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajps.2026.101121_bib0071","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ajps.2026.101121_bib0072","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"Aav vector immunogenicity in humans: a long journey to successful gene transfer","volume":"28","author":"Costa Verdera","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0073","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.ajps.2026.101121_bib0074","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ajps.2026.101121_bib0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0076","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/14760584.2021.1988854","article-title":"Use of lentiviral vectors in vaccination","volume":"20","author":"Ku","year":"2021","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.ajps.2026.101121_bib0077","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood.2024024523","article-title":"In vivo CAR T -cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand","volume":"144","author":"Nicolai","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ajps.2026.101121_bib0078","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.ajps.2026.101121_bib0079","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/pharmaceutics14081605","article-title":"Lentiviral vectors for ocular gene therapy","volume":"14","author":"Arsenijevic","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nprot.2009.22","article-title":"Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors","volume":"4","author":"Kutner","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajps.2026.101121_bib0081","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa2113206","article-title":"Betibeglogene autotemcel gene therapy for non\u2013\u03b20\/\u03b20 genotype \u03b2-thalassemia","volume":"386","author":"Locatelli","year":"2022","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0082","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa2206575","article-title":"Lentiviral gene therapy for artemis-deficient SCID","volume":"387","author":"Cowan","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0083","first-page":"5702","article-title":"Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors","volume":"4","author":"Frank","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajps.2026.101121_bib0084","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41587-019-0325-6","article-title":"Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency","volume":"38","author":"Nguyen","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0086","doi-asserted-by":"crossref","first-page":"eabq0603","DOI":"10.1126\/scitranslmed.abq0603","article-title":"Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination","volume":"15","author":"Suberi","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0087","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41565-023-01548-3","article-title":"Combinatorial development of nebulized mRNA delivery formulations for the lungs","volume":"19","author":"Jiang","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0088","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1039\/D4PY00234B","article-title":"Advancing nucleic acid delivery through cationic polymer design: non-cationic building blocks from the toolbox","volume":"15","author":"Porello","year":"2024","journal-title":"Polym Chem"},{"key":"10.1016\/j.ajps.2026.101121_bib0089","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100938","article-title":"Near-infrared light-triggered polyprodrug\/siRNA loaded upconversion nanoparticles for multi-modality imaging and synergistic cancer therapy","volume":"10","author":"Kuang","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0090","first-page":"71","article-title":"Polyethyleneimine (PEI) as a polymer-based co-delivery system for breast cancer therapy","volume":"14","author":"Fahira","year":"2022","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ajps.2026.101121_bib0091","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201707113","article-title":"PLGA spherical nucleic acids","volume":"30","author":"Zhu","year":"2018","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0092","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actbio.2018.04.006","article-title":"Customizing poly(lactic-co-glycolic acid) particles for biomedical applications","volume":"73","author":"Swider","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2026.101121_bib0093","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/adhm.201600160","article-title":"pH-switch nanoprecipitation of polymeric nanoparticles for multimodal cancer targeting and intracellular triggered delivery of doxorubicin","volume":"5","author":"Herranz-Blanco","year":"2016","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0094","doi-asserted-by":"crossref","first-page":"9860","DOI":"10.3390\/ijms23179860","article-title":"Sensitivity of the transport of plastic nanoparticles to typical phosphates associated with ionic strength and solution pH","volume":"23","author":"Liu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.ajps.2026.101121_bib0096","doi-asserted-by":"crossref","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","article-title":"Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and toxoplasma gondii challenges with a single dose","volume":"113","author":"Chahal","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajps.2026.101121_bib0097","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/acs.accounts.9b00053","article-title":"Understanding nanoparticle toxicity mechanisms to inform redesign strategies to reduce environmental impact","volume":"52","author":"Buchman","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0098","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0099","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/1061186X.2015.1048519","article-title":"Targeted polymeric nanoparticles for cancer gene therapy","volume":"23","author":"Kim","year":"2015","journal-title":"J Drug Target"},{"key":"10.1016\/j.ajps.2026.101121_bib0100","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.molpharmaceut.3c00231","article-title":"Lipoic acid-based poly(disulfide)s as versatile biomolecule delivery vectors and the application in tumor immunotherapy","volume":"20","author":"Hei","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ajps.2026.101121_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122464","article-title":"Protein-based nanoparticles for therapeutic nucleic acid delivery","volume":"305","author":"Eweje","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2026.101121_bib0102","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0104","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1039\/D2CS00106C","article-title":"Polymersome-based protein drug delivery - quo vadis?","volume":"52","author":"Gouveia","year":"2023","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2012.04.036","article-title":"Protein-based nanocarriers as promising drug and gene delivery systems","volume":"161","author":"Elzoghby","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0106","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tibtech.2017.11.007","article-title":"Protein-based therapeutic killing for cancer therapies","volume":"36","author":"Serna","year":"2018","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0107","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/pharmaceutics15020525","article-title":"Multimeric rgd-based strategies for selective drug delivery to tumor tissues","volume":"15","author":"Cossu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0108","doi-asserted-by":"crossref","first-page":"2314898","DOI":"10.1002\/adfm.202314898","article-title":"Oncolytic virus-like nanoparticles for tumor-specific gene delivery","volume":"34","author":"Li","year":"2024","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0109","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/pharmaceutics16091172","article-title":"Exploring protein-based carriers in drug delivery: a review","volume":"16","author":"Ferraro","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0110","doi-asserted-by":"crossref","first-page":"994655","DOI":"10.3389\/fbioe.2022.994655","article-title":"Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy","volume":"10","author":"Cheng","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0111","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/polym15040836","article-title":"Recent progress in proteins-based micelles as drug delivery carriers","volume":"15","author":"Mustafai","year":"2023","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ajps.2026.101121_bib0112","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.addr.2020.06.020","article-title":"Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles","volume":"156","author":"Luther","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0113","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cis.2017.02.009","article-title":"Aqueous-phase synthesis of iron oxide nanoparticles and composites for cancer diagnosis and therapy","volume":"249","author":"Li","year":"2017","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0114","article-title":"Design and synthesize of folate decorated Fe3O4@Au-DEX-CP nano formulation for targeted drug delivery in colorectal cancer therapy: in vitro and in vivo studies","volume":"87","author":"Alnasraui","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ajps.2026.101121_bib0115","doi-asserted-by":"crossref","DOI":"10.1063\/5.0129824","article-title":"Effect of laser parameter on fe3o4 nps formation by pulsed laser ablation in liquid","volume":"2769","author":"Abdulwahid","year":"2023","journal-title":"AIP Conf Proc"},{"issue":"41","key":"10.1016\/j.ajps.2026.101121_bib0116","doi-asserted-by":"crossref","first-page":"23894","DOI":"10.1039\/C9RA03608C","article-title":"Functionalized gold nanostructures: promising gene delivery vehicles in cancer treatment","volume":"9","author":"Kumar","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.ajps.2026.101121_bib0117","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12951-020-00613-6","article-title":"Application of magnetic nanoparticles in nucleic acid detection","volume":"18","author":"Tang","year":"2020","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.ajps.2026.101121_bib0118","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1039\/C5CS00541H","article-title":"In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles","volume":"44","author":"Arami","year":"2015","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0119","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1021\/acs.bioconjchem.7b00368","article-title":"Recent developments in antimicrobial-peptide-conjugated gold nanoparticles","volume":"28","author":"Rajchakit","year":"2017","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.ajps.2026.101121_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124057","article-title":"Gold nanoparticles-mediated photothermal and photodynamic therapies for cancer","volume":"655","author":"Turkmen Koc","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2026.101121_bib0121","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/mt.2014.30","article-title":"Gold nanoparticles for nucleic acid delivery","volume":"22","author":"Ding","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0122","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.3390\/molecules25153489","article-title":"Gold nanoparticles for vectorization of nucleic acids for cancer therapeutics","volume":"25","author":"Ferreira","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ajps.2026.101121_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127184","article-title":"A comprehensive review of cancer therapies mediated by conjugated gold nanoparticles with nucleic acid","volume":"253","author":"Hosseini","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajps.2026.101121_bib0124","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1038\/s41467-021-23250-5","article-title":"Programmably tiling rigidified DNA brick on gold nanoparticle as multi-functional shell for cancer-targeted delivery of siRNAs","volume":"12","author":"Xue","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0125","article-title":"Engineered silica nanoparticles for nucleic acid delivery","volume":"8","author":"Zhang","year":"2024","journal-title":"Small Meth"},{"key":"10.1016\/j.ajps.2026.101121_bib0126","doi-asserted-by":"crossref","first-page":"38873","DOI":"10.1021\/acsami.0c07106","article-title":"Combination of nucleic acid and mesoporous silica nanoparticles: optimization and therapeutic performance in vitro","volume":"12","author":"Juneja","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2026.101121_bib0127","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3390\/molecules22050782","article-title":"Mesoporous silica nanoparticles as carriers for intracellular delivery of nucleic acids and subsequent therapeutic applications","volume":"22","author":"Cha","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ajps.2026.101121_bib0128","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1050928","article-title":"Nanocarriers containing platinum compounds for combination chemotherapy","volume":"13","author":"Fang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajps.2026.101121_bib0129","doi-asserted-by":"crossref","first-page":"17761","DOI":"10.1039\/C8NR04254C","article-title":"Magnetic nanoparticles loaded with functional RNA nanoparticles","volume":"10","author":"Cruz-Acu\u00f1a","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.ajps.2026.101121_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/toxics5040029","article-title":"Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro\/in vivo toxicity evaluation","volume":"5","author":"De Matteis","year":"2017","journal-title":"Toxics"},{"key":"10.1016\/j.ajps.2026.101121_bib0131","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.153818","article-title":"Potential toxicity of inorganic ions in particulate matter: ion permeation in lung and disruption of cell metabolism","volume":"824","author":"Park","year":"2022","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.ajps.2026.101121_bib0132","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","article-title":"Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications","volume":"144","author":"Mohammadpour","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0133","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1038\/s41467-023-38364-1","article-title":"Design of bacteriophage t4-based artificial viral vectors for human genome remodeling","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0134","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ajps.2026.101121_bib0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/pharmaceutics12070607","article-title":"Development of lipid\u2013polymer hybrid nanoparticles for improving oral absorption of enoxaparin","volume":"12","author":"Tang","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0136","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","article-title":"Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects","volume":"20","author":"Kiaie","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0137","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0138","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0139","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery","volume":"344","author":"Maeki","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajps.2026.101121_bib0141","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0142","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ajps.2026.101121_bib0143","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye","volume":"303","author":"Patel","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0144","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0145","article-title":"Unsaturated, trialkyl ionizable lipids are versatile lipid-nanoparticle components for therapeutic and vaccine applications","volume":"35","author":"Lam","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0146","doi-asserted-by":"crossref","first-page":"29045","DOI":"10.1021\/acsnano.4c10154","article-title":"Tetrahydropyrimidine ionizable lipids for efficient mRNA delivery","volume":"18","author":"Isaac","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101121_bib0147","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206968","article-title":"Biodegradable cationic and ionizable cationic lipids: a roadmap for safer pharmaceutical excipients","volume":"19","author":"J\u00f6rgensen","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.ajps.2026.101121_bib0148","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1039\/D3TB00649B","article-title":"Rational design and combinatorial chemistry of ionizable lipids for RNA delivery","volume":"11","author":"Xu","year":"2023","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.ajps.2026.101121_bib0149","article-title":"One-component cationic lipids for systemic mRNA delivery to splenic T cells","volume":"63","author":"Zhang","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.ajps.2026.101121_bib0150","article-title":"MRNA vaccines against SARS-CoV-2 variants delivered by lipid nanoparticles based on novel ionizable lipids","volume":"32","author":"Chen","year":"2022","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0151","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41551-024-01265-9","article-title":"Immunogenic amines on lipid nanoparticles","volume":"8","author":"Sharma","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ajps.2026.101121_bib0152","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.3390\/molecules28104046","article-title":"Ionizable lipids with triazole moiety from click reaction for LNP-based mRNA delivery","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ajps.2026.101121_bib0153","article-title":"Peptide-driven proton sponge nano-assembly for imaging and triggering lysosome-regulated immunogenic cancer cell death","volume":"36","author":"He","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0154","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","article-title":"Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry","volume":"23","author":"Li","year":"2024","journal-title":"Nat Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0155","doi-asserted-by":"crossref","first-page":"eaba1028","DOI":"10.1126\/sciadv.aba1028","article-title":"Ionizable lipid nanoparticles for in utero mRNA delivery","volume":"7","author":"Riley","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2026.101121_bib0156","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202470228","article-title":"Tumor-tailored ionizable lipid nanoparticles facilitate IL-12 circular RNA delivery for enhanced lung cancer immunotherapy","volume":"36","author":"Xu","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/thno.89913","article-title":"Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery","volume":"14","author":"Patel","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2026.101121_bib0158","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/342718","article-title":"Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients","volume":"71","author":"Dabora","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ajps.2026.101121_bib0159","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","article-title":"Lipid nanoparticle-mRNA formulations for therapeutic applications","volume":"54","author":"Wang","year":"2021","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0160","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101121_bib0161","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for siRNA delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0162","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0163","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202528","article-title":"Delivering mRNA to secondary lymphoid tissues by phosphatidylserine-loaded lipid nanoparticles","volume":"12","author":"Gomi","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0164","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41563-020-00886-0","article-title":"Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and crispr\u2013cas gene editing","volume":"20","author":"Liu","year":"2021","journal-title":"Nat Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0166","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101121_bib0167","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jconrel.2022.05.020","article-title":"Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells","volume":"347","author":"Patel","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0168","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","volume":"351","author":"Zimmermann","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0169","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307801120","article-title":"Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart","volume":"121","author":"Radmand","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajps.2026.101121_bib0170","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0171","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303857","article-title":"Modulating lipid nanoparticles with histidinamide-conjugated cholesterol for improved intracellular delivery of mRNA","volume":"13","author":"Jung","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0172","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.canlet.2013.03.011","article-title":"Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy","volume":"334","author":"Sharma","year":"2013","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.ajps.2026.101121_bib0173","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","article-title":"Lipid nanoparticles with peg-variant surface modifications mediate genome editing in the mouse retina","volume":"14","author":"Gautam","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0174","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ajps.2026.101121_bib0175","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","article-title":"Agile platform: a deep learning powered approach to accelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0176","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajps.2026.101121_bib0177","first-page":"0370","article-title":"Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies","volume":"7","author":"Huang","year":"2024","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.ajps.2026.101121_bib0178","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater Au"},{"key":"10.1016\/j.ajps.2026.101121_bib0179","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/pharmaceutics12111095","article-title":"Manufacturing considerations for the development of lipid nanoparticles using microfluidics","volume":"12","author":"Roces","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0180","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/pharmaceutics15071819","article-title":"Development of an alcohol dilution-lyophilization method for the preparation of mRNA-LNPs with improved storage stability","volume":"15","author":"Shirane","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0181","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2010.02.029","article-title":"Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles","volume":"144","author":"Zhigaltsev","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0182","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2019.10.028","article-title":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening","volume":"316","author":"Guimaraes","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0183","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1039\/D3NH00217A","article-title":"Microfluidic synthesis of nanomaterials for biomedical applications","volume":"8","author":"Huang","year":"2023","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.ajps.2026.101121_bib0184","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-024-06589-5","article-title":"Development of an extended action fostemsavir lipid nanoparticle","volume":"7","author":"Islam","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.ajps.2026.101121_bib0186","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1021\/acs.molpharmaceut.2c00033","article-title":"Comparison of DLin-MC3-DMA and ALC-0315 for siRNA delivery to hepatocytes and hepatic stellate cells","volume":"19","author":"Ferraresso","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ajps.2026.101121_bib0187","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0188","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-019-12275-6","article-title":"Linkage between endosomal escape of LNP-mRNA and loading into evs for transport to other cells","volume":"10","author":"Maugeri","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0189","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajps.2026.101121_bib0190","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.ajps.2026.101121_bib0191","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.biomaterials.2013.11.016","article-title":"Neutral biodegradable lipid-envelope-type nanoparticle using vitamin A-scaffold for nuclear targeting of plasmid DNA","volume":"35","author":"Tanaka","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2026.101121_bib0192","first-page":"125","article-title":"Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach","volume":"34","author":"Young","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0193","doi-asserted-by":"crossref","DOI":"10.1080\/14686996.2024.2338785","article-title":"Fine tuning of the net charge alternation of polyzwitterion surfaced lipid nanoparticles to enhance cellular uptake and membrane fusion potential","volume":"25","author":"Homma","year":"2024","journal-title":"Sci Technol Adv Mater"},{"issue":"1","key":"10.1016\/j.ajps.2026.101121_bib0194","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41551-024-01296-2","article-title":"Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulations","volume":"9","author":"Ho\u0142ubowicz","year":"2025","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.ajps.2026.101121_bib0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","article-title":"Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles","volume":"343","author":"Evers","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0196","doi-asserted-by":"crossref","first-page":"16151","DOI":"10.1021\/acsnano.4c01171","article-title":"High-throughput in vivo screening identifies differential influences on mRNA lipid nanoparticle immune cell delivery by administration route","volume":"18","author":"Hamilton","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101121_bib0197","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904905","article-title":"Mild innate immune activation overrides efficient nanoparticle-mediated RNA delivery","volume":"32","author":"Lokugamage","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0198","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ajps.2026.101121_bib0199","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ajps.2026.101121_bib0200","article-title":"Esterase-labile quaternium lipidoid enabling improved mRNA-LNP stability and spleen-selective mRNA transfection","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0201","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0202","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","article-title":"MRNA-based therapeutics: looking beyond COVID-19 vaccines","volume":"403","author":"Parhiz","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ajps.2026.101121_bib0203","doi-asserted-by":"crossref","first-page":"eabf4398","DOI":"10.1126\/sciadv.abf4398","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.ajps.2026.101121_bib0204","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0205","doi-asserted-by":"crossref","DOI":"10.4028\/b-fVvR5S","article-title":"Design PD-L1-targeted lipid nanoparticles to turn on PTEN for efficient cancer therapy","volume":"11","author":"Kim","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ajps.2026.101121_bib0206","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2024.05.036","article-title":"EGFR -targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta","volume":"371","author":"Geisler","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0207","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","article-title":"PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake","volume":"291","author":"Parhiz","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0208","doi-asserted-by":"crossref","first-page":"20163","DOI":"10.1021\/acsnano.2c04829","article-title":"Interaction kinetics of individual mRNA-containing lipid nanoparticles with an endosomal membrane mimic: dependence on pH, protein corona formation, and lipoprotein depletion","volume":"16","author":"Aliakbarinodehi","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101121_bib0209","article-title":"Novel vectors and approaches for gene therapy in liver diseases","volume":"3","author":"Maestro","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ajps.2026.101121_bib0210","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202401445","article-title":"Tuning lipid nanoparticles for RNA delivery to extrahepatic organs","volume":"36","author":"Song","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0211","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ymthe.2024.02.028","article-title":"Smart-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants","volume":"32","author":"Mahalingam","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0212","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/cancers11050640","article-title":"Active targeting strategies using biological ligands for nanoparticle drug delivery systems","volume":"11","author":"Yoo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajps.2026.101121_bib0213","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1038\/s41467-024-48461-4","article-title":"Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles","volume":"15","author":"Bian","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0214","doi-asserted-by":"crossref","first-page":"9119","DOI":"10.1038\/s41467-024-53569-8","article-title":"Structuring lipid nanoparticles, DNA, and protein corona into stealth bionanoarchitectures for in vivo gene delivery","volume":"15","author":"Renzi","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0215","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201095","article-title":"Anionic lipid nanoparticles preferentially deliver mRNA to the hepatic reticuloendothelial system","volume":"34","author":"Pattipeiluhu","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0216","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid nanoparticle technology for clinical translation of siRNA therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0217","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904905","article-title":"Mild innate immune activation overrides efficient nanoparticle-mediated RNA delivery","volume":"32","author":"Lokugamage","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0218","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymthe.2024.01.005","article-title":"The landscape of nanoparticle-based siRNA delivery and therapeutic development","volume":"32","author":"Moazzam","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0219","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ajps.2026.101121_bib0220","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J Hepatol"},{"issue":"50","key":"10.1016\/j.ajps.2026.101121_bib0221","doi-asserted-by":"crossref","first-page":"34375","DOI":"10.1021\/acsnano.4c13404","article-title":"Prevent and reverse metabolic dysfunction-associated steatohepatitis and hepatic fibrosis via mRNA-mediated liver-specific antibody therapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101121_bib0222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012502","article-title":"Development of a lipid-encapsulated tgf\u03b2ri-siRNA drug for liver fibrosis induced by Schistosoma mansoni","volume":"18","author":"Chen","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ajps.2026.101121_bib0223","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011254","article-title":"Encapsulation of dexamethasone into mRNA-lipid nanoparticles is a promising approach for the development of liver-targeted anti-inflammatory therapies","volume":"25","author":"Rivero Berti","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0224","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJMoa2300757","article-title":"Patisiran treatment in patients with transthyretin cardiac amyloidosis","volume":"389","author":"Maurer","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130595","article-title":"Construction of nanoparticles from blueberry anthocyanins-lecithin\/gum arabic improves lipid droplet accumulation and gut microbiota disturbance in HFD-induced obese mice","volume":"264","author":"Cheng","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.ajps.2026.101121_bib0226","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jconrel.2022.08.058","article-title":"Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen","volume":"350","author":"Al Fayez","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0227","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jconrel.2024.10.028","article-title":"Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo","volume":"376","author":"Wu","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0228","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12989-017-0212-6","article-title":"Prenatal tobacco smoke exposure predisposes offspring mice to exacerbated allergic airway inflammation associated with altered innate effector function","volume":"14","author":"Ferrini","year":"2017","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.ajps.2026.101121_bib0229","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1111\/bph.15621","article-title":"Lung pharmacokinetics of inhaled and systemic drugs: a clinical evaluation","volume":"178","author":"Sadiq","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajps.2026.101121_bib0230","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","article-title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model","volume":"75","author":"Yang","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajps.2026.101121_bib0231","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajps.2026.101121_bib0232","doi-asserted-by":"crossref","first-page":"25698","DOI":"10.1021\/acsami.4c02415","article-title":"Cationic lipid pairs enhance liver-to-lung tropism of lipid nanoparticles for in vivo mRNA delivery","volume":"16","author":"Zeng","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2026.101121_bib0233","doi-asserted-by":"crossref","first-page":"eadg6229","DOI":"10.1126\/scitranslmed.adg6229","article-title":"TGF-\u03b2R2 signaling coordinates pulmonary vascular repair after viral injury in mice and human tissue","volume":"16","author":"Zhao","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0234","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1021\/acs.nanolett.3c03547","article-title":"Inhalable gene therapy and the lung surfactant problem","volume":"23","author":"Kassab","year":"2023","journal-title":"Nano Lett"},{"key":"10.1016\/j.ajps.2026.101121_bib0235","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ajps.2026.101121_bib0236","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1158\/1535-7163.MCT-23-0915","article-title":"A novel lipid nanoparticle nbf-006 encapsulating glutathione s-transferase p siRNA for the treatment of KRAS-driven non\u2013small cell lung cancer","volume":"24","author":"Cina","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ajps.2026.101121_bib0237","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2022.09.021","article-title":"Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery","volume":"351","author":"Zimmermann","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0238","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0239","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0240","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/nano12122072","article-title":"Peptidomimetic lipid-nanoparticle-mediated knockdown of tlr4 in CNS protects against cerebral ischemia\/reperfusion injury in mice","volume":"12","author":"Ganbold","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.ajps.2026.101121_bib0241","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1039\/D3NA00699A","article-title":"Ionic liquid-coated lipid nanoparticles increase siRNA uptake into CNS targets","volume":"6","author":"Khare","year":"2024","journal-title":"Nanoscale Adv"},{"key":"10.1016\/j.ajps.2026.101121_bib0242","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1021\/acsnano.3c09817","article-title":"Targeted mRNA nanoparticles ameliorate blood-brain barrier disruption postischemic stroke by modulating microglia polarization","volume":"18","author":"Gao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101121_bib0243","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(03)00310-6","article-title":"A global control region defines a chromosomal regulatory landscape containing the HoxD cluster","volume":"113","author":"Spitz","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ajps.2026.101121_bib0244","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jconrel.2024.04.006","article-title":"A blood-brain barrier- and blood-brain tumor barrier-penetrating siRNA delivery system targeting gliomas for brain tumor immunotherapy","volume":"369","author":"Tang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molmed.2023.02.004","article-title":"Brain gene therapy with Trojan horse lipid nanoparticles","volume":"29","author":"Pardridge","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0246","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2022.05.042","article-title":"Focused ultrasound\/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain","volume":"348","author":"Ogawa","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0247","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309225","article-title":"Nanoparticle-mediated delivery of anti-pu.1 siRNA via localized intracisternal administration reduces neuroinflammation","volume":"36","author":"Ralvenius","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0248","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120786","article-title":"Granulocyte-macrophage colony-stimulating factor mRNA and neuroprotective immunity in Parkinson\u2019s disease","volume":"272","author":"Olson","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ajps.2026.101121_bib0249","article-title":"Functionalized lipid nanoparticles modulate the blood-brain barrier and eliminate \u03b1-synuclein to repair dopamine neurons","volume":"19","author":"Wu","year":"2024","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0250","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202470093","article-title":"Lipid and transcriptional regulation in a parkinson\u2019s disease mouse model by intranasal vesicular and hexosomal plasmalogen-based nanomedicines","volume":"13","author":"Wu","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0251","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.ajps.2026.101121_bib0252","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2024.06.023","article-title":"Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: advances in genome editing and CAR T cell therapy","volume":"372","author":"Soroudi","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0253","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.1912012117","article-title":"Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier","volume":"117","author":"OA","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajps.2026.101121_bib0254","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102175","article-title":"Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system","volume":"35","author":"Parhiz","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ajps.2026.101121_bib0255","article-title":"Lipid nanoparticles deliver the therapeutic VEGFA mRNA in vitro and in vivo and transform extracellular vesicles for their functional extensions","volume":"10","author":"Nawaz","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ajps.2026.101121_bib0256","doi-asserted-by":"crossref","first-page":"28480","DOI":"10.1021\/acsnano.4c06369","article-title":"Immune implications of cholesterol-containing lipid nanoparticles","volume":"18","author":"Back","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ajps.2026.101121_bib0257","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1194\/jlr.M012872","article-title":"SiRNA-induced liver apob knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids","volume":"52","author":"Tadin-Strapps","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0258","doi-asserted-by":"crossref","first-page":"61565","DOI":"10.1021\/acsami.4c10032","article-title":"Lipid nanoparticle-mediated Oip5-as1 delivery preserves mitochondrial function in myocardial ischemia\/reperfusion injury by inhibiting the p53 pathway","volume":"16","author":"Niu","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ajps.2026.101121_bib0259","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.7150\/thno.77350","article-title":"Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ajps.2026.101121_bib0260","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2022.03.021","article-title":"Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy","volume":"345","author":"Liu","year":"2022","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.ajps.2026.101121_bib0261","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.ymthe.2024.12.019","article-title":"mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions","volume":"33","author":"Nguyen","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0262","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajps.2026.101121_bib0263","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","article-title":"Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model","volume":"75","author":"Yang","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajps.2026.101121_bib0264","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.ymthe.2022.05.018","article-title":"Precision medicine: in vivo CAR therapy as a showcase for receptor-targeted vector platforms","volume":"30","author":"Michels","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0265","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54877-9","article-title":"Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity","volume":"15","author":"Hamouda","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0266","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409812","article-title":"Simplified lipid nanoparticles for tissue- and cell-targeted mRNA delivery facilitate precision tumor therapy in a lung metastasis mouse model","volume":"36","author":"Fei","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.ajps.2026.101121_bib0267","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ymthe.2024.01.020","article-title":"Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines","volume":"32","author":"Kubara","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0268","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-bioeng-110220-031722","article-title":"Current developments and challenges of mRNA vaccines","volume":"24","author":"Chen","year":"2022","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.ajps.2026.101121_bib0269","doi-asserted-by":"crossref","first-page":"eabn3464","DOI":"10.1126\/scitranslmed.abn3464","article-title":"Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice","volume":"15","author":"Ramos da Silva","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0270","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002852","article-title":"STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation","volume":"9","author":"Nakamura","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ajps.2026.101121_bib0271","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.actbio.2024.12.003","article-title":"Personalized membrane protein vaccine based on a lipid nanoparticle delivery system prevents postoperative recurrence in colorectal cancer models","volume":"192","author":"Shi","year":"2025","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ajps.2026.101121_bib0272","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1336906","article-title":"The mRNA-LNP vaccines: the good, the bad and the ugly?","volume":"15","author":"Igy\u00e1rt\u00f3","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajps.2026.101121_bib0273","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1466337","article-title":"Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics","volume":"15","author":"Vasileva","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajps.2026.101121_bib0274","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3390\/pharmaceutics14122682","article-title":"Recent advances in lipid nanoparticles for delivery of mRNA","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2026.101121_bib0275","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s12272-018-1069-4","article-title":"The cutting-edge technologies of siRNA delivery and their application in clinical trials","volume":"41","author":"Lee","year":"2018","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0276","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115461","article-title":"Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids","volume":"215","author":"Bader","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajps.2026.101121_bib0277","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1021\/acs.accounts.1c00500","article-title":"Developing biodegradable lipid nanoparticles for intracellular mRNA delivery and genome editing","volume":"54","author":"Qiu","year":"2021","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ajps.2026.101121_bib0278","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid nanoparticles enabling gene therapies: from concepts to clinical utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0279","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41392-024-01871-8","article-title":"Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection","volume":"9","author":"Zai","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jacbts.2021.07.012","article-title":"Translation of new and emerging therapies for genetic cardiomyopathies","volume":"7","author":"Helms","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ajps.2026.101121_bib0281","doi-asserted-by":"crossref","first-page":"9884","DOI":"10.1038\/s41467-024-54289-9","article-title":"A self-amplifying RNA RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and na\u00efve non-human primates","volume":"15","author":"Vijayan","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2026.101121_bib0282","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2021.10.010","article-title":"Ultrasound-targeted nucleic acid delivery for solid tumor therapy","volume":"339","author":"Schwartz","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0283","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.122.001234","article-title":"RNAi-based therapeutics and novel RNA bioengineering technologies","volume":"384","author":"Traber","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajps.2026.101121_bib0284","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","article-title":"Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies - challenges and opportunities","volume":"370","author":"Simonsen","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2026.101121_bib0285","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/jpm14111092","article-title":"Advances in mRNA LNP -based cancer vaccines: mechanisms, formulation aspects, challenges, and future directions","volume":"14","author":"Ramadan","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.ajps.2026.101121_bib0286","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.omtn.2023.06.023","article-title":"Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice","volume":"33","author":"Yamazaki","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ajps.2026.101121_bib0287","article-title":"Nano-energy interference: a novel strategy for blunting tumor adaptation and metastasis","volume":"25","author":"Teng","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.ajps.2026.101121_bib0288","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1557\/s43577-021-00169-2","article-title":"Nucleic acid delivery and nanoparticle design for COVID vaccines","volume":"46","author":"Andresen","year":"2021","journal-title":"MRS Bull"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087626000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087626000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:53:30Z","timestamp":1777622010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087626000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":288,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1818087626000073"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2026.101121","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolution of lipid nanoparticles: Paving the way for next-generation nucleic acid medicines","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2026.101121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101121"}}